DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 7 Aug · 11:56 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has submitted copies of newspaper clippings to the exchanges as required under SEBI's Listing Regulations. The clippings, published on August 7, 2025, in Financial Express (English) and Andhra Prabha (Telugu), contain the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). These results were approved by the Board on August 6, 2025, based on the Audit Committee's recommendation. The filing is a routine compliance submission to make the quarterly results publicly available via newspapers; the detailed numbers are hosted on the company's investor relations page.

Likely market impact

This is a routine regulatory disclosure with no new financial information beyond what was already announced on August 6, 2025. No material impact on the stock is expected from this filing itself.